Trials / Enrolling By Invitation
Enrolling By InvitationNCT07239453
Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects
An Open-Label, Randomized, Single Oral Dose, Two-Sequence, Two-Period, CrossovSer Bioequivalence Study of "DA-2902" and "DA-2902-R" in Healthy Adults Under Fed Conditions
- Status
- Enrolling By Invitation
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
This study is to compare pharmacokinetics and safety profiles of DA-2902 and DA-2902-R in healthy adult subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-2902 | single dose administration (DA-2902 one tablet once a day) |
| DRUG | DA-2902-R | single dose administration (DA-2902-R one tablet once a day) |
Timeline
- Start date
- 2025-10-20
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-11-20
- Last updated
- 2025-11-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07239453. Inclusion in this directory is not an endorsement.